Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
C-Rad AB Class B ( ($SE:CRAD.B) ) has issued an update.
C-RAD has announced a leadership change with CEO Cecilia de Leeuw stepping down and CFO Linda Frölén taking over as acting CEO. Johan Danielsson has been appointed deputy CEO, and board member Peter Simonsbacka will consult to boost activity levels. The company is actively recruiting a new CEO. This transition aims to maintain the company’s momentum in the market, particularly in enhancing the quality of life for cancer patients through their SGRT technology.
The most recent analyst rating on ($SE:CRAD.B) stock is a Hold with a SEK35.00 price target. To see the full list of analyst forecasts on C-Rad AB Class B stock, see the SE:CRAD.B Stock Forecast page.
More about C-Rad AB Class B
C-RAD is a company that specializes in developing surface-guided imaging solutions for radiation therapy. Their technology ensures accurate dose delivery to tumors while protecting healthy tissue, utilizing high-speed 3D cameras and augmented reality to enhance patient safety and comfort. C-RAD is listed on NASDAQ Stockholm.
Average Trading Volume: 40,835
Technical Sentiment Signal: Sell
Current Market Cap: SEK1.12B
For an in-depth examination of CRAD.B stock, go to TipRanks’ Overview page.